Validity and use of a non-parallel insulin assay for pharmacokinetic studies of the rapid-acting insulin analogue, insulin aspart

被引:7
作者
Andersen, L [1 ]
Volund, A [1 ]
Olsen, KJ [1 ]
Plum, A [1 ]
Walsh, D [1 ]
机构
[1] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
关键词
D O I
10.1081/IAS-100103226
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A radioimmunoassay (RIA) for insulin was validated for reliable measurement of the human insulin analogue, insulin aspart, by correction of non-linear measurements. Specificity was equivalent for several species of insulin, except insulin aspart. A non-linear hyperbolic model fitted insulin aspart with a correction formula for non-linearity of. z = 1503y/(1398 - y), where y denotes measured concentration and z denotes true concentration. Matrix-effects were insignificant for human, porcine, and canine heparin-plasma and for human and porcine serum. The coefficient of variation was below 15% for 80-800 pmol/L human and porcine insulin and for 80-600 pmol/L insulin aspart. The limit of detection for insulin aspart was 11.5 pmol/L with a lower limit of quantification of 17.5 pmol/L. Dilution of serum with Pharmacia dilution media introduced no significant error. In conclusion, this paper demonstrates that a non-parallel radioimmuno assay can be used to estimate accurate concentrations of insulin aspart.
引用
收藏
页码:147 / 163
页数:17
相关论文
共 14 条
[1]  
ANDERSEN L, 1993, CLIN CHEM, V39, P578
[2]  
ANDERSEN L, UNPUB CLIN BIOCH
[3]   INSULIN DEGRADATION IN-VITRO AND IN-VIVO - A COMPARATIVE-STUDY IN MEN - EVIDENCE THAT IMMUNOPRECIPITABLE, PARTIALLY REBINDABLE DEGRADATION PRODUCTS ARE RELEASED FROM CELLS AND CIRCULATE IN BLOOD [J].
BENZI, L ;
CECCHETTI, P ;
CICCARONE, A ;
PILO, A ;
DICIANNI, G ;
NAVALESI, R .
DIABETES, 1994, 43 (02) :297-304
[4]   MONOMERIC INSULINS OBTAINED BY PROTEIN ENGINEERING AND THEIR MEDICAL IMPLICATIONS [J].
BRANGE, J ;
RIBEL, U ;
HANSEN, JF ;
DODSON, G ;
HANSEN, MT ;
HAVELUND, S ;
MELBERG, SG ;
NORRIS, F ;
NORRIS, K ;
SNEL, L ;
SORENSEN, AR ;
VOIGT, HO .
NATURE, 1988, 333 (6174) :679-682
[5]   MONOMERIC INSULINS AND THEIR EXPERIMENTAL AND CLINICAL IMPLICATIONS [J].
BRANGE, J ;
OWENS, DR ;
KANG, S ;
VOLUND, A .
DIABETES CARE, 1990, 13 (09) :923-954
[6]  
*DAKO DIAGN LTD, 1994, DAKO INS ELISA DIR U
[7]   SUPERIORITY OF SANDWICH ELISA OVER COMPETITIVE RIA FOR THE ESTIMATION OF ANP-270, AN ANALOG OF HUMAN ATRIAL-NATRIURETIC-FACTOR [J].
INGWERSEN, SH ;
JORGENSEN, PN ;
EISKJAER, H ;
JOHANSEN, NL ;
MADSEN, K ;
FAARUP, P .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 149 (02) :237-246
[8]  
OWENS DR, 1986, HUMAN INSULIN CLIN P, P48
[9]  
*PHARM DIAGN AB, 1987, PHARM INS RIA 100 DI
[10]   ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE AND PHARMACOKINETIC STUDIES [J].
SHAH, VP ;
MIDHA, KK ;
DIGHE, S ;
MCGILVERAY, IJ ;
SKELLY, JP ;
YACOBI, A ;
LAYLOFF, T ;
VISWANATHAN, CT ;
COOK, CE ;
MCDOWALL, RD ;
PITTMAN, KA ;
SPECTOR, S ;
ALBERT, KS ;
BOLTON, S ;
COOK, CE ;
DIGHE, S ;
DOBRINSKA, M ;
DOUB, W ;
EICHELBAUM, M ;
FINDLAY, JWA ;
GALLICANO, K ;
GARLAND, W ;
HARDY, DJ ;
HULSE, JD ;
KARNES, HT ;
MCDOWALL, RD ;
LANGE, R ;
LAYLOFF, T ;
MASON, WD ;
MCKAY, G ;
MCGILVERAY, IJ ;
MIDHA, KK ;
ORMSBY, E ;
OVERPECK, J ;
PITTMAN, KA ;
PLATTENBERG, HD ;
SHAH, VP ;
SHIU, G ;
SITAR, D ;
SKELLY, JP ;
SORGEL, F ;
SPECTOR, S ;
STEWART, JT ;
VISWANATHAN, CT ;
YACOBI, A ;
YUH, L .
PHARMACEUTICAL RESEARCH, 1992, 9 (04) :588-592